Ablative Therapies for Liver Tumors.

Area of Science:

• Hepatobiliary Medicine
• Surgical Oncology
• Interventional Radiology

Background:

• Hepatocellular carcinoma and colorectal liver metastasis are leading causes of cancer mortality.
• Surgical resection and transplantation are standard curative treatments for liver tumors.
• Minimally invasive ablative therapies are emerging as effective alternatives, enhancing cure rates and reducing morbidity.

Purpose of the Study:

• To review the role and advancements of minimally invasive ablative therapies in liver tumor management.
• To highlight the significance of patient selection and technological integration for optimal outcomes.

Main Methods:

• Literature review of ablative therapies for primary and metastatic liver tumors.
• Analysis of current treatment standards, including surgery and transplantation.
• Evaluation of emerging technologies and patient selection criteria.

Main Results:

• Ablative therapies provide a viable alternative to traditional surgery for liver tumors.
• These therapies increase the potential for cure while minimizing patient complications.
• Technological advancements are crucial for refining patient selection and treatment modalities.

Conclusions:

• Minimally invasive ablative therapies are integral to modern liver tumor management.
• Careful patient selection and the strategic application of advanced technologies are essential for maximizing treatment efficacy and improving patient outcomes.